| Ident. | Authors (with country if any) | Title |
|---|
| 000013 (2020) |
Adrien Breiman [France] ; Nathalie Ruvën-Clouet [France] ; Jacques Le Pendu [France] | Harnessing the natural anti-glycan immune response to limit the transmission of enveloped viruses such as SARS-CoV-2 |
| 000019 (2020) |
Y J Liu [République populaire de Chine] ; Y L Yang [République populaire de Chine] ; Y. Xu [République populaire de Chine] | [What we learned from SARS may provide important insights into understanding and management of coronavirus disease 2019]. |
| 000030 (2020) |
Yeyan He [République populaire de Chine] ; Chanying Zheng [République populaire de Chine] | [Replication and transmission mechanisms of highly pathogenic human coronaviruses]. |
| 000034 (2020) |
Y. Shi [République populaire de Chine] ; N. Wang [République populaire de Chine] ; Q M Zou [République populaire de Chine] | [Progress and challenge of vaccine development against 2019 novel coronavirus (2019-nCoV)]. |
| 000040 (2020) |
X. Wang [République populaire de Chine] ; Y Q Ding [République populaire de Chine] | [From SARS to COVID-19: pathogens, receptor, pathogenesis and principles of the treatment]. |
| 000045 (2020) |
Zheng Chen [République populaire de Chine] ; Li-Zhong Du ; Jun-Fen Fu ; Qiang Shu ; Zhi-Min Chen ; Li-Ping Shi ; Wei Wang ; Shuo-Hui Chen ; Xiao-Lu Ma ; Sheng Ye ; Wei Sun ; Ming-Yan Chen ; Hai-Hong Zhu ; Guo-Lan Huang ; Fei-Xiang Luo | [Emergency plan for inter-hospital transfer of newborns with SARS-CoV-2 infection]. |
| 000055 (2020) |
J. Wang [République populaire de Chine] ; B J Wang [République populaire de Chine] ; J C Yang [République populaire de Chine] ; M Y Wang [République populaire de Chine] ; C. Chen [République populaire de Chine] ; G X Luo [République populaire de Chine] ; W F He [République populaire de Chine] | [Advances in the research of mechanism of pulmonary fibrosis induced by Corona Virus Disease 2019 and the corresponding therapeutic measures]. |
| 000062 (2020) |
Binqing Fu [République populaire de Chine] ; Xiaoling Xu [République populaire de Chine] ; Haiming Wei [République populaire de Chine] | Why tocilizumab could be an effective treatment for severe COVID-19? |
| 000099 (2020) |
Yong Xiong [République populaire de Chine] ; Yuan Liu [République populaire de Chine] ; Liu Cao [République populaire de Chine] ; Dehe Wang [République populaire de Chine] ; Ming Guo [République populaire de Chine] ; Ao Jiang [République populaire de Chine] ; Dong Guo [République populaire de Chine] ; Wenjia Hu [République populaire de Chine] ; Jiayi Yang [République populaire de Chine] ; Zhidong Tang [République populaire de Chine] ; Honglong Wu [République populaire de Chine] ; Yongquan Lin [République populaire de Chine] ; Meiyuan Zhang [République populaire de Chine] ; Qi Zhang [République populaire de Chine] ; Mang Shi [République populaire de Chine] ; Yingle Liu [République populaire de Chine] ; Yu Zhou [République populaire de Chine] ; Ke Lan [République populaire de Chine] ; Yu Chen [République populaire de Chine] | Transcriptomic characteristics of bronchoalveolar lavage fluid and peripheral blood mononuclear cells in COVID-19 patients. |
| 000111 (2020) |
Rohit Shetty [Inde] ; Arkasubhra Ghosh [Inde] ; Santosh G. Honavar [Inde] ; Pooja Khamar [Inde] ; Swaminathan Sethu [Inde] | Therapeutic opportunities to manage COVID-19/SARS-CoV-2 infection: Present and future. |
| 000122 (2020) |
Qing Ye [République populaire de Chine] ; Bili Wang [République populaire de Chine] ; Jianhua Mao [République populaire de Chine] | The pathogenesis and treatment of the `Cytokine Storm' in COVID-19. |
| 000151 (2020) |
Peter P. Liu [Canada] ; Alice Blet [France] ; David Smyth [Canada] ; Hongliang Li [République populaire de Chine] | The Science Underlying COVID-19: Implications for the Cardiovascular System. |
| 000158 (2020) |
Peter J. Hotez ; Maria Elena Bottazzi ; David B. Corry | The Potential Role of Th17 Immune Responses in Coronavirus Immunopathology and Vaccine-induced Immune Enhancement |
| 000185 (2020) |
Rameez Jabeer Khan [Inde] ; Rajat Kumar Jha [Inde] ; Gizachew Muluneh Amera [Inde] ; Monika Jain [Inde] ; Ekampreet Singh [Inde] ; Amita Pathak [Inde] ; Rashmi Prabha Singh [Inde] ; Jayaraman Muthukumaran [Inde] ; Amit Kumar Singh [Inde] | Targeting SARS-CoV-2: a systematic drug repurposing approach to identify promising inhibitors against 3C-like proteinase and 2'-O-ribose methyltransferase. |
| 000223 (2020) |
Furong Qi [République populaire de Chine] ; Shen Qian [République populaire de Chine] ; Shuye Zhang [République populaire de Chine] ; Zheng Zhang [République populaire de Chine] | Single cell RNA sequencing of 13 human tissues identify cell types and receptors of human coronaviruses |
| 000250 (2020) |
Miyu Moriyama [États-Unis] ; Walter J. Hugentobler ; Akiko Iwasaki [États-Unis] | Seasonality of Respiratory Viral Infections. |
| 000254 (2020) |
Di Mauro Gabriella ; Scavone Cristina ; Rafaniello Concetta ; Rossi Francesco ; Capuano Annalisa | SARS-Cov-2 infection: response of human immune system and possible implications for the rapid test and treatment |
| 000260 (2020) |
Rafal Butowt [Pologne] ; Katarzyna Bilinska [Pologne] | SARS-CoV-2: Olfaction, Brain Infection, and the Urgent Need for Clinical Samples Allowing Earlier Virus Detection. |
| 000274 (2020) |
Janko Nikolich-Zugich [États-Unis] ; Kenneth S. Knox [États-Unis] ; Carlos Tafich Rios [États-Unis] ; Bhupinder Natt [États-Unis] ; Deepta Bhattacharya [États-Unis] ; Mindy J. Fain [États-Unis] | SARS-CoV-2 and COVID-19 in older adults: what we may expect regarding pathogenesis, immune responses, and outcomes |
| 000278 (2020) |
Daniel Stadlbauer [États-Unis] ; Fatima Amanat [États-Unis] ; Veronika Chromikova [États-Unis] ; Kaijun Jiang [États-Unis] ; Shirin Strohmeier [États-Unis] ; Guha Asthagiri Arunkumar [États-Unis] ; Jessica Tan [États-Unis] ; Disha Bhavsar [États-Unis] ; Christina Capuano [États-Unis] ; Ericka Kirkpatrick [États-Unis] ; Philip Meade [États-Unis] ; Ruhi Nichalle Brito [États-Unis] ; Catherine Teo [États-Unis] ; Meagan Mcmahon [États-Unis] ; Viviana Simon [États-Unis] ; Florian Krammer [États-Unis] | SARS-CoV-2 Seroconversion in Humans: A Detailed Protocol for a Serological Assay, Antigen Production, and Test Setup. |
| 000300 (2020) |
Ashley Barlow [États-Unis] ; Kaitlin M. Landolf [États-Unis] ; Brooke Barlow [États-Unis] ; Siu Yan Amy Yeung [États-Unis] ; Jason J. Heavner [États-Unis] ; Cassidy W. Claassen [Zambie] ; Mojdeh S. Heavner [États-Unis] | Review of Emerging Pharmacotherapy for the Treatment of Coronavirus Disease 2019. |
| 000321 (2020) |
Angela Ceribelli [Italie] ; Francesca Motta [Italie] ; Maria De Santis [Italie] ; Aftab A. Ansari [États-Unis] ; William M. Ridgway [États-Unis] ; M. Eric Gershwin [États-Unis] ; Carlo Selmi [Italie] | Recommendations for coronavirus infection in rheumatic diseases treated with biologic therapy |
| 000376 (2020) |
Syed Faraz Ahmed ; Ahmed A. Quadeer ; Matthew R. Mckay [République populaire de Chine] | Preliminary Identification of Potential Vaccine Targets for the COVID-19 Coronavirus (SARS-CoV-2) Based on SARS-CoV Immunological Studies |
| 000387 (2020) |
Farid Rahimi [Australie] ; Amin Talebi Bezmin Abadi [Iran] | Practical Strategies Against the Novel Coronavirus and COVID-19-the Imminent Global Threat. |
| 000403 (2020) |
Francesco Di Pierro [Oman] ; Alexander Bertuccioli [Italie] ; Ilaria Cavecchia [Italie] | Possible therapeutic role of a highly standardized mixture of active compounds derived from cultured Lentinula edodes mycelia (AHCC) in patients infected with 2019 novel coronavirus. |
| 000417 (2020) |
Guangyu Zhou [République populaire de Chine] ; Qi Zhao [République populaire de Chine] | Perspectives on therapeutic neutralizing antibodies against the Novel Coronavirus SARS-CoV-2 |
| 000426 (2020) |
James Lyons-Weiler | Pathogenic priming likely contributes to serious and critical illness and mortality in COVID-19 via autoimmunity |
| 000441 (2020) |
Henry Ji [États-Unis] ; Ying Yan [États-Unis] ; Beibei Ding [États-Unis] ; Wenzhong Guo [États-Unis] ; Mark Brunswick [États-Unis] ; Andreas Niethammer [États-Unis] ; Williams Soohoo [États-Unis] ; Robin Smith [États-Unis] ; Alexis Nahama [États-Unis] ; Yanliang Zhang [États-Unis] | Novel decoy cellular vaccine strategy utilizing transgenic antigen-expressing cells as immune presenter and adjuvant in vaccine prototype against SARS-CoV-2 virus. |
| 000444 (2020) |
Arinjay Banerjee [Canada] ; Michelle L. Baker [Australie] ; Kirsten Kulcsar [États-Unis] ; Vikram Misra [Canada] ; Raina Plowright [États-Unis] ; Karen Mossman [Canada] | Novel Insights Into Immune Systems of Bats |
| 000468 (2020) |
Xiaowei Li [République populaire de Chine] ; Manman Geng [République populaire de Chine] ; Yizhao Peng [République populaire de Chine] ; Liesu Meng [République populaire de Chine] ; Shemin Lu [République populaire de Chine] | Molecular immune pathogenesis and diagnosis of COVID-19 |
| 000471 (2020) |
Bruno Tilocca [Italie] ; Alessio Soggiu [Italie] ; Vincenzo Musella [Italie] ; Domenico Britti [Italie] ; Maurizio Sanguinetti [Italie] ; Andrea Urbani [Italie] ; Paola Roncada [Italie] | Molecular basis of COVID-19 relationships in different species: a one health perspective. |
| 000481 (2020) |
Eun Kim [États-Unis] ; Geza Erdos [États-Unis] ; Shaohua Huang [États-Unis] ; Thomas W. Kenniston [États-Unis] ; Stephen C. Balmert [États-Unis] ; Cara Donahue Carey [États-Unis] ; V. Stalin Raj [Pays-Bas] ; Michael W. Epperly [États-Unis] ; William B. Klimstra [États-Unis] ; Bart L. Haagmans [Pays-Bas] ; Emrullah Korkmaz [États-Unis] ; Louis D. Falo [États-Unis] ; Andrea Gambotto [États-Unis] | Microneedle array delivered recombinant coronavirus vaccines: Immunogenicity and rapid translational development |
| 000482 (2020) |
Ashok K. Shetty | Mesenchymal Stem Cell Infusion Shows Promise for Combating Coronavirus (COVID-19)- Induced Pneumonia |
| 000496 (2020) |
Tiago Torres [Portugal] ; Luis Puig [Espagne] | Managing Cutaneous Immune-Mediated Diseases During the COVID-19 Pandemic |
| 000506 (2020) |
Li Runfeng [République populaire de Chine] ; Hou Yunlong [République populaire de Chine] ; Huang Jicheng [République populaire de Chine] ; Pan Weiqi [République populaire de Chine] ; Ma Qinhai [République populaire de Chine] ; Shi Yongxia [République populaire de Chine] ; Li Chufang [République populaire de Chine] ; Zhao Jin [République populaire de Chine] ; Jia Zhenhua [République populaire de Chine] ; Jiang Haiming [République populaire de Chine] ; Zheng Kui [République populaire de Chine] ; Huang Shuxiang [République populaire de Chine] ; Dai Jun [République populaire de Chine] ; Li Xiaobo [République populaire de Chine] ; Hou Xiaotao [République populaire de Chine] ; Wang Lin [République populaire de Chine] ; Zhong Nanshan [République populaire de Chine] ; Yang Zifeng [République populaire de Chine] | Lianhuaqingwen exerts anti-viral and anti-inflammatory activity against novel coronavirus (SARS-CoV-2). |
| 000527 (2020) |
Jason A. Tetro | Is COVID-19 receiving ADE from other coronaviruses? |
| 000551 (2020) |
P. Conti [Italie] ; G. Ronconi [Italie] ; A. Caraffa [Italie] ; C. Gallenga [Italie] ; R. Ross [États-Unis] ; I. Frydas [Grèce] ; S. Kritas [Grèce] | Induction of pro-inflammatory cytokines (IL-1 and IL-6) and lung inflammation by Coronavirus-19 (COVI-19 or SARS-CoV-2): anti-inflammatory strategies. |
| 000564 (2020) |
Ruklanthi De Alwis [Singapour] ; Shiwei Chen [Singapour] ; Esther S. Gan [Singapour] ; Eng Eong Ooi [Singapour] | Impact of immune enhancement on Covid-19 polyclonal hyperimmune globulin therapy and vaccine development |
| 000566 (2020) |
Vargab Baruah [Inde] ; Sujoy Bose [Inde] | Immunoinformatics-aided identification of T cell and B cell epitopes in the surface glycoprotein of 2019-nCoV. |
| 000567 (2020) |
Eakachai Prompetchara [Thaïlande] ; Chutitorn Ketloy [Thaïlande] ; Tanapat Palaga [Thaïlande] | Immune responses in COVID-19 and potential vaccines: Lessons learned from SARS and MERS epidemic. |
| 000568 (2020) |
Mohsen Rokni [Iran] ; Vida Ghasemi [Iran] ; Zahra Tavakoli [Iran] | Immune responses and pathogenesis of SARS-CoV-2 during an outbreak in Iran: Comparison with SARS and MERS. |
| 000580 (2020) |
Ling Lin [République populaire de Chine] ; Lianfeng Lu [République populaire de Chine] ; Wei Cao [République populaire de Chine] ; Taisheng Li [République populaire de Chine] | Hypothesis for potential pathogenesis of SARS-CoV-2 infection-a review of immune changes in patients with viral pneumonia. |
| 000586 (2020) |
P. Conti [Italie] ; C E Gallenga [Italie] ; G. Tetè [Italie] ; Al Caraffa [Italie] ; G. Ronconi [Italie] ; A. Younes [Italie] ; E. Toniato [Italie] ; R. Ross [États-Unis] ; S K Kritas [Grèce] | How to reduce the likelihood of coronavirus-19 (CoV-19 or SARS-CoV-2) infection and lung inflammation mediated by IL-1. |
| 000636 (2020) |
David Marx [France] ; Bruno Moulin [France] ; Samira Fafi-Kremer [France] ; Ilies Benotmane [France] ; Gabriela Gautier [France] ; Peggy Perrin [France] ; Sophie Caillard [France] | First case of COVID-19 in a kidney transplant recipient treated with belatacept. |
| 000666 (2020) |
Amr H. Sawalha [États-Unis] ; Ming Zhao [République populaire de Chine] ; Patrick Coit [États-Unis] ; Qianjin Lu [République populaire de Chine] | Epigenetic dysregulation of ACE2 and interferon-regulated genes might suggest increased COVID-19 susceptibility and severity in lupus patients |
| 000698 (2020) |
Juanjuan Zhao [République populaire de Chine] ; Xuejiao Liao [République populaire de Chine] ; Haiyan Wang [République populaire de Chine] ; Lanlan Wei [République populaire de Chine] ; Mingzhao Xing [République populaire de Chine] ; Lei Liu [République populaire de Chine] ; Zheng Zhang [République populaire de Chine] | Early virus clearance and delayed antibody response in a case of COVID-19 with a history of co-infection with HIV-1 and HCV. |
| 000760 (2020) |
Lorenzo D'Antiga [Italie] | Coronaviruses and immunosuppressed patients. The facts during the third epidemic. |
| 000771 (2020) |
Harapan Harapan [Indonésie] ; Naoya Itoh [Japon] ; Amanda Yufika [Indonésie] ; Wira Winardi [Indonésie] ; Synat Keam [Australie] ; Heyhpeng Te [Cambodge] ; Dewi Megawati [Indonésie, États-Unis] ; Zinatul Hayati [Indonésie] ; Abram L. Wagner [États-Unis] ; Mudatsir Mudatsir [Indonésie] | Coronavirus disease 2019 (COVID-19): A literature review |
| 000787 (2020) |
P. Conti [Italie] ; A. Younes [Italie] | Coronavirus COV-19/SARS-CoV-2 affects women less than men: clinical response to viral infection. |
| 000790 (2020) |
Jaime A. Teixeira Da Silva | Convalescent plasma: A possible treatment of COVID-19 in India |
| 000792 (2020) |
Stephen J. Carter [États-Unis] ; Marissa N. Baranauskas [États-Unis] ; Alyce D. Fly [États-Unis] | Considerations for obesity, vitamin D, and physical activity amidst the COVID-19 pandemic. |
